DRG Market Assessment reports

Clarivate Epidemiology’s coverage of asthma comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of asthma for each country, as…

Clarivate Epidemiology’s coverage of asthma comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of asthma for each country, as…

Clarivate Epidemiology’s coverage of asthma comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of asthma for each country, as…

Clarivate Epidemiology’s coverage of asthma comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of asthma for each country, as…

Clarivate Epidemiology’s coverage of asthma comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy,…

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key asthma patient populations, covering 171 countries and more than 99…

Clarivate Epidemiology’s coverage of asthma comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the diagnosed prevalence of asthma for each…

Clarivate Epidemiology’s coverage of acute respiratory distress syndrome (ARDS) comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the…

Clarivate Epidemiology’s coverage of the RSV vaccine comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany…

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disorder characterized by an irreversible loss of lung function. Pirfenidone was the first disease-modifying therapy (DMT) approved for IPF,…

In 2022, sales of branded biologics for respiratory indications totaled about $2.3 billion in the major pharmaceutical markets under study (United States, EU5, and Japan). Throughout our 2022-2032…

Asthma is a common chronic airway disease that affects children and adults. The asthma therapy market in China consists of many well-established agents, including inhaled agents (GSK’s Advair /…